Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Olaparib becomes first gene-targeted medicine to show benefits in prostate cancer

worldpharmanewsDecember 10, 2019

Tag: Olaparib , gene-targeted medicine , Prostate Cancer

PharmaSources Customer Service